Company: CI
Filing Date: 2025-03-14
Form Type: DEF 14A
Source: 0001739940-25-000015
Chunk: 61

Company: Cigna Group
Filing Date: 2025-03-14
Form: DEF 14A
Chunk 61
---
 | % |
| Overall EIP Calculated Funding Factor                                                                                                                                                                                                                                   |     | 99%                   |    |   |
| Committee Discretionary Adjustment                                                                                                                                                                                                                                      |     |                       | -7 | % |
| Committee Approved EIP Funding Amount                                                                                                                                                                                                                                   |     |                       | 92 | % |

The Committee considered the Company’s performance relative to each of the performance measures, overall performance over the latter part of the year, as well as various other factors, when determining the approved funding amount. The Committee approved funding the EIP pool at 92%, which it believes is reflective of the Company’s performance in 2024 and aligns with the Committee’s pay for performance philosophy.

(1) We encourage you to review our Annual Report on Form 10-K for the year ended December 31, 2024 for more complete financial information. Adjusted income from operations and adjusted revenues are financial measures used by the Company that are not determined in accordance with generally accepted accounting principles in the United States (GAAP). The Committee may make adjustments to the actual levels of achievement under each performance measure to: (i) exclude the impact of any unusual or extraordinary results that do not reflect the ongoing business operations and/or that are not the result of normal business risks; and (ii) avoid creating unintended incentives for management to make decisions solely based on achieving incentive results. Additional information regarding these measures, including definitions and reconciliations to the most directly comparable GAAP measures, namely shareholders net income and total revenues, respectively, can be found on Annex A.

| The Cigna Group| 2025 Notice of Annual Meeting of Shareholders and Proxy Statement |     | 65 |

| COMPENSATION MATTERS |

2024 Individual EIP Targets and Awards

EIP target levels and actual awards for the 2024 performance year for each of the NEOs are set forth in the table below. EIP target levels are reflective of the Committee’s (and with respect to Mr. Cordani’s, the independent members of the Board’s) review of target total direct compensation positioning and other factors as further discussed above. In determining actual payout amounts, the Committee (and for Mr. Cordani, the independent members of the Board upon the recommendation of the Committee) started with the approved EIP funding amount as the baseline for EIP awards and then assessed each NEO’s individual contributions during 2024. Payouts under the 2024 EIP rewarded our NEOs for our performance in 2024, reflecting pay-for